1-(1-Ethylpiperazin-4-yl)-3-bromoisoquinoline → 1-(4-Ethylpiperazin-1-yl)-3-[4-(3-oxobutyl)phenyl]isoquinoline

HRID 1251247Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1251247
C([Sn](CCCC)(CCCC)[C:6]1[CH:11]=[CH:10][C:9]([CH2:12][CH2:13][C:14](=[O:16])[CH3:15])=[CH:8][CH:7]=1)CCC.Br[C:26]1[N:27]=[C:28]([N:36]2[CH2:41][CH2:40][N:39]([CH2:42][CH3:43])[CH2:38][CH2:37]2)[C:29]2[C:34]([CH:35]=1)=[CH:33][CH:32]=[CH:31][CH:30]=2>C1(C)C(C)=CC=CC=1.C(OCC)(=O)C.C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[CH2:42]([N:39]1[CH2:38][CH2:37][N:36]([C:28]2[C:29]3[C:34](=[CH:33][CH:32]=[CH:31][CH:30]=3)[CH:35]=[C:26]([C:6]3[CH:7]=[CH:8][C:9]([CH2:12][CH2:13][C:14](=[O:16])[CH3:15])=[CH:10][CH:11]=3)[N:27]=2)[CH2:41][CH2:40]1)[CH3:43]

Komponenten

6

Edukt 2

HCID 225024471-(1-Ethylpiperazin-4-yl)-3-bromoisoquinolineHCID 225026514-(4-Tributylstannylphenyl)-2-butanone

Produkt 1

HCID 225031951-(4-Ethylpiperazin-1-yl)-3-[4-(3-oxobutyl)phenyl]isoquinolineAusbeute 62,7 %

Reagenzien, Katalysatoren, Lösungsmittel 3

HCID 178418397HCID 178418397, VerbindungKatalysatorHCID 7237O-XyleneLösungsmittelHCID 8857Ethyl AcetateLösungsmittel

Versuchsvorschrift

4-(4-Tributylstannylphenyl)-2-butanone (2.46 g) and 3-bromo-1-(4-ethylpiperazin-1-yl)isoquinoline (1.41 g) were heated under reflux in the presence of tetrakistriphenylphosphinepalladium(0) (0.22 g) in xylene in nitrogen atmosphere overnight. After cooling, the reaction solution was diluted with ethyl acetate and filtered. The filtrate was extracted in 2N hydrochloric acid, and the resulting aqueous layer was washed with ethyl acetate, adjusted to pH 10 with a 8N aqueous solution of sodium hydroxide, and then extracted with ethyl acetate. The extract was washed with a 10% aqueous solution of sodium carbonate and brine, and dried over magnesium sulfate. The solvent was evaporated, and the resulting residue was purified by silica gel column chromatography (toluene/acetone system), to give 1-(4-ethylpiperazin-1-yl)-3-[4-(3-oxobutyl)phenyl]isoquinoline (1.07 g) as a pale yellow viscous oil.

Aufarbeitung

  1. temperatureAfter cooling
  2. filtrationfiltered
  3. extractionThe filtrate was extracted in 2N hydrochloric acid
  4. washthe resulting aqueous layer was washed with ethyl acetate
  5. extractionextracted with ethyl acetate
  6. washThe extract was washed with a 10% aqueous solution of sodium carbonate and brine
  7. dry with materialdried over magnesium sulfate
  8. customThe solvent was evaporated
  9. customthe resulting residue was purified by silica gel column chromatography (toluene/acetone system)

Quellen und Nachweise

ORD-Eintrag
ord-1ebd5611c54f482d881a43394ad36802
Quelldatensatz
uspto-grants-2002_01
Patentnummer
US06340759B1

Notizen zur Reaktion

Wird geladen…